Skip to main content
Clinical Trials/NCT02621203
NCT02621203
Unknown
Not Applicable

Investigate to Medications, Re-hospitalization and Mortality of Patients With Hospitalized Acute Heart Failure Patients

Mehdi Zoghi1 site in 1 country1,000 target enrollmentSeptember 2015
ConditionsHeart Failure

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Heart Failure
Sponsor
Mehdi Zoghi
Enrollment
1000
Locations
1
Primary Endpoint
all cause mortality
Last Updated
10 years ago

Overview

Brief Summary

A multicentre, prospective, observational, hospital-based registry of patients with acute heart failure (AHF) those whose care was guided by a cardiologist in Turkey.

Detailed Description

The purpose of this study is to compose a national database of the etiologies, clinical and demographic characteristics, using diagnostic tests, precipitating and risk factors, management of from intensive care unit (ICU) or coronary care unit to hospital discharge, length of stay in the ICU and hospital, in-hospital mortality and discharge medications of hospitalized AHF patients in Turkish population. The etiologies, precipitating factors, demographics, clinical characteristics, management and outcome of patients admitted in hospital with acute heart failure in Turkish population will be recorded.

Registry
clinicaltrials.gov
Start Date
September 2015
End Date
August 2016
Last Updated
10 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Mehdi Zoghi
Responsible Party
Sponsor Investigator
Principal Investigator

Mehdi Zoghi

Prof.

Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital

Eligibility Criteria

Inclusion Criteria

  • Patients \>18 years old
  • Clinical diagnosis of acute heart failure
  • Admitted to the participating hospitals

Exclusion Criteria

  • Patients \<18 years old
  • Patients with acute heart failure who are discharged from the emergency room without admission.
  • Failure to obtain informed consent

Outcomes

Primary Outcomes

all cause mortality

Time Frame: 3 months

Secondary Outcomes

  • Hospitalization(3 months)

Study Sites (1)

Loading locations...

Similar Trials